AGP Wire
Stay informed with articles highlighting the latest developments, major events, and essential updates.
Uttar Pradesh Tourism heads to World Travel Market London 2026
AGP
Uttar Pradesh Tourism will use World Travel Market London 2026, running Nov. 3-5 at ExCeL London, to pitch the state’s spiritual, cultural, heritage and experiential tourism to global buyers.
Airo launches inhalation system in the UK with SOMAÍ and IPS Pharma
AGP
Airo Brands and SOMAÍ have launched the AiroPro inhalation system in the United Kingdom, with IPS Pharma as exclusive distributor.
Doctor Turka says many UK Turkey teeth plans call for unnecessary crowns
AGP
Istanbul dental clinic Doctor Turka says its review of 50,000 patient conversations suggests many UK dental tourism plans overuse crowns, including on teeth that could be treated with veneers, bonding or no treatment.
Specscart lands in FT and Statista’s ranking of the UK’s fastest-growing companies
AGP
Specscart, the Manchester-based eyewear retailer, is the only eyewear brand included in the Financial Times and Statista’s first ranking of the UK’s fastest-growing companies.
Madhya Pradesh Tourism heads to WTM London 2026 with wide-ranging showcase
AGP
Madhya Pradesh Tourism will present its cultural, wildlife and heritage attractions at WTM London 2026 from Nov. 3-5 at ExCeL London.
Beovu market seen growing on retinal disease demand and aging populations
AGP
The Business Research Company says the global Beovu market is expanding as retinal disease rates rise, older populations grow and healthcare spending increases.
Bayhep B market set for growth on hepatitis B demand and aging population
AGP
The Business Research Company says the Bayhep B market will keep expanding through 2026, driven by higher hepatitis B prevalence, more liver transplant activity, and broader use of post-exposure prophylaxis.
Berinert market seen expanding through 2030 on better diagnosis and access
AGP
The Business Research Company says the Berinert market is set for continued growth through 2030 as hereditary angioedema diagnosis improves, healthcare spending rises and more patients gain access to plasma-derived treatments.
Creon market seen growing on pancreatic disease burden and personalized care
AGP
The Creon market is projected to expand as pancreatic disorders rise, healthcare spending increases and personalized medicine gains ground.
Clevecord market forecast points to steady growth through 2035
AGP
The Business Research Company says the Clevecord market is set for steady expansion through 2035 as stem cell therapies, healthcare spending and aging populations increase demand.
Coagadex market seen expanding through 2030 on rare bleeding disorder demand
AGP
The Coagadex market is projected to grow through 2030 as diagnosis rates rise, home infusion expands and access improves in emerging markets.
Cordcyte market outlook points to faster growth in stem cell therapies
AGP
The Business Research Company says the Cordcyte market is set for notable expansion through 2035, driven by chronic disease demand, more clinical trials and rising healthcare spending.
Cotazym market seen growing through 2030 on digestive care demand
AGP
The Business Research Company says the Cotazym market is being lifted by rising gastrointestinal disease, more diagnoses of pancreatic insufficiency and broader use of enzyme replacement therapy.
Besremi market seen growing on rising MPN diagnoses and longer-acting treatments
AGP
The Business Research Company says the Besremi market is poised for steady expansion through 2035, driven by rising diagnoses of myeloproliferative neoplasms, growing use of longer-acting interferons, and broader access to specialty hematology…
Cyfendus market set for faster growth as anthrax preparedness spending rises
AGP
The global Cyfendus vaccine market is gaining momentum as governments step up biodefense planning and anthrax preparedness.
Betaferon and Betaseron market seen growing as MS cases rise
AGP
The Business Research Company says the global Betaferon or Betaseron market has long-term growth potential through 2035, driven by rising multiple sclerosis diagnoses, ongoing demand for cost-effective therapies, and broader use in emerging…
Comirnaty market forecast to double by 2030 as booster demand stays strong
AGP
The Business Research Company says the global Comirnaty (tozinameran) market will grow from $8.26 million in 2025 to $21.81 million by 2030, fueled by booster demand, mRNA adoption and pandemic preparedness spending.
Crofab market study points to steady growth, led by North America
AGP
The Business Research Company says the Crofab market is expanding as snakebite cases, emergency care demand and healthcare spending rise.
RennerVation Foundation gets 2027 Noble Deeds support
AGP
RennerVation Foundation has been named the 2027 Noble Deeds recipient, giving the Nevada nonprofit a year of pro bono marketing support to help more foster youth access its programs.
Daptacel market seen expanding on vaccination demand
AGP
The Daptacel vaccine market is projected to keep growing through the forecast period as childhood immunization programs, infectious disease pressure and travel-related disease risk support demand.
Sign up for:
United Kingdom News Watch
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.